Verruca Viral

Group A patients will receive intralesional injection of upto 0.5 mL of reconstituted MMR vaccine into a single or a maximum of 5 warts at a time in case of multiple warts. Intralesional injection will be given every three weeks for a maximum of 5 doses or until complete resolution, whichever is earlier.

Measles-Mumps-Rubella Vaccine

Group B patients will receive a maximum of 0.5 mL Inj. Vitamin D3 (600,000 IU; 15mg/ml) in each session after injection of IL lignocaine with 31 G insulin syringe. In cases of multiple warts, a maximum of 5 warts will be injected at a time. The session will be done at 3 weekly intervals for a maximum of 5 sessions or until complete resolution of warts, whichever is earlier

Vit D

BP Koirala Institute of Health Sciences

A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts

A Comparative Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Warts

Percentage of patients showing complete response to IL MMR

Percentage of patients showing complete response to IL Vitamin D3

Sex distribution of wart patients in male, female or others group

Ethnicity distribution of wart patients into Brahmin,Chhetri, Madhesi, Dalit, Janajati, Muslim, others

Distribution of wart patients into different education level like professional degree, graduate, intermediate, high school, middle school, primary school or illiterate

Number of participants with different occupations like professional, semiprofessional, clerical/shop/farm, skilled worker, semiskilled worker, unskilled worker, unemployed

Number of participants with different progressions of warts like Gradual or rapid or stable or regressing lesions

Frequency of associated symptoms like pain, pruritus or burning sensation associated with warts

Frequency of any associated diseases like Diabetes, Asthma, Allergic skin disorders

Frequency of different types of past treatment taken- either traditional or medical treatments

Frequency of past treatment taken- either traditional or medical treatments

DLQI will be measured using standard Nepali version of DLQI

Dr. Bibisha Baaniya

Junior Resident

B.P. Koirala Institute of Health Sciences

Nepal Health Research Council

Group A - will receive IL MMR Group B- will receive IL Vitamin D3

Only patients will be blinded to the randomization and intervention.

mumps/ödem

A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen